- Home
- Publications
- Publication Search
- Publication Details
Title
Repositioning rifamycins for Mycobacterium abscessus lung disease
Authors
Keywords
-
Journal
Expert Opinion on Drug Discovery
Volume 14, Issue 9, Pages 867-878
Publisher
Informa UK Limited
Online
2019-06-14
DOI
10.1080/17460441.2019.1629414
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased drug permeability of a stiffened mycobacterial outer membrane in cells lacking MFS transporter Rv1410 and lipoprotein LprG
- (2019) Michael Hohl et al. MOLECULAR MICROBIOLOGY
- Select β-Lactam Combinations Exhibit Synergy against Mycobacterium abscessus In Vitro
- (2019) Elizabeth Story-Roller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Synergism of Rifabutin with Clarithromycin, Imipenem, and Tigecycline against the Mycobacterium abscessus Complex
- (2019) Aristine Cheng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro and Intracellular Activity of Imipenem Combined with Tedizolid, Rifabutin, and Avibactam against Mycobacterium abscessus
- (2019) Eva Le Run et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
- (2019) Rebekah M. Dedrick et al. NATURE MEDICINE
- Rifabutin acts in synergy and is bactericidal with frontline Mycobacterium abscessus antibiotics clarithromycin and tigecycline, suggesting a potent treatment combination
- (2018) Mark Pryjma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High Levels of Intrinsic Tetracycline Resistance in Mycobacterium abscessus Are Conferred by a Tetracycline-Modifying Monooxygenase
- (2018) Paulami Rudra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ambroxol induces autophagy and potentiates Rifampin antimycobacterial activity
- (2018) Seong Won Choi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro and intracellular activity of imipenem combined to rifabutin and avibactam against Mycobacterium abscessus
- (2018) Eva Le Run et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- NTM drug discovery: status, gaps and the way forward
- (2018) Mu-Lu Wu et al. DRUG DISCOVERY TODAY
- Challenges of NTM Drug Development
- (2018) Joseph O. Falkinham Frontiers in Microbiology
- Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT): A Prospective, Open-Label, Randomized Study
- (2018) David E Griffith et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Mode of Action of Kanglemycin A, an Ansamycin Natural Product that Is Active against Rifampicin-Resistant Mycobacterium tuberculosis
- (2018) Hamed Mosaei et al. MOLECULAR CELL
- Treatment of Mycobacterium abscessus Complex
- (2018) Kevin Winthrop et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Treatment of Mycobacterium avium Complex (MAC)
- (2018) David Griffith SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- The Role of Antibiotic-Target-Modifying and Antibiotic-Modifying Enzymes in Mycobacterium abscessus Drug Resistance
- (2018) Sakshi Luthra et al. Frontiers in Microbiology
- ALIS (Amikacin Liposome Inhalation Suspension): The Beginning of a Wonderland?
- (2018) Charles L. Daley et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Advancing Translational Science for Pulmonary NTM Infections: A Roadmap for Research
- (2018) Shelby Daniel-Wayman et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism
- (2018) James Peek et al. Nature Communications
- Treatment outcomes of rifabutin-containing regimens for rifabutin-sensitive multidrug-resistant pulmonary tuberculosis
- (2017) Hyun Lee et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus
- (2017) Anna Rominski et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Elucidation of Mycobacterium abscessus aminoglycoside and capreomycin resistance by targeted deletion of three putative resistance genes
- (2017) Anna Rominski et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Susceptibility Testing of Tedizolid against Nontuberculous Mycobacteria
- (2017) Barbara A. Brown-Elliott et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition
- (2017) Wei Lin et al. MOLECULAR CELL
- Predictive compound accumulation rules yield a broad-spectrum antibiotic
- (2017) Michelle F. Richter et al. NATURE
- The Diverse Cellular and Animal Models to Decipher the Physiopathological Traits of Mycobacterium abscessus Infection
- (2017) Audrey Bernut et al. Frontiers in Cellular and Infection Microbiology
- Screening of TB Actives for Activity against Nontuberculous Mycobacteria Delivers High Hit Rates
- (2017) Jian Liang Low et al. Frontiers in Microbiology
- Lipoprotein Glycosylation by Protein-O-Mannosyltransferase (MAB_1122c) Contributes to Low Cell Envelope Permeability and Antibiotic Resistance of Mycobacterium abscessus
- (2017) Katja Becker et al. Frontiers in Microbiology
- Biofilm Formation byMycobacterium abscessusin a Lung Cavity
- (2016) Kevin P. Fennelly et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease
- (2016) Beatriz E. Ferro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intrinsic rifamycin resistance ofMycobacterium abscessusis mediated by ADP-ribosyltransferase MAB_0591
- (2016) Anna Rominski et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Innovation in the pharmaceutical industry: New estimates of R&D costs
- (2016) Joseph A. DiMasi et al. JOURNAL OF HEALTH ECONOMICS
- Pulmonary Disease Caused by Non-Tuberculous Mycobacteria
- (2016) Nasstasja Wassilew et al. RESPIRATION
- The distinct fate of smooth and roughMycobacterium abscessusvariants inside macrophages
- (2016) Anne-Laure Roux et al. Open Biology
- Mild Nutrient Starvation Triggers the Development of a Small-Cell Survival Morphotype in Mycobacteria
- (2016) Mu-Lu Wu et al. Frontiers in Microbiology
- Susceptibility of Mycobacterium abscessus to Antimycobacterial Drugs in Preclinical Models
- (2015) Andrés Obregón-Henao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Treatment of Rapidly Growing Mycobacterial Infections
- (2015) Shannon H. Kasperbauer et al. CLINICS IN CHEST MEDICINE
- Chronic pulmonary disease withMycobacterium abscessuscomplex is a biofilm infection
- (2015) Tavs Qvist et al. EUROPEAN RESPIRATORY JOURNAL
- The association between sterilizing activity and drug distribution into tuberculosis lesions
- (2015) Brendan Prideaux et al. NATURE MEDICINE
- Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery
- (2015) Meenal Datta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nontuberculous Mycobacteria in Cystic Fibrosis and Non–Cystic Fibrosis Bronchiectasis
- (2015) In Park et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China
- (2015) Hui Pang et al. Biomed Research International
- Lack of Antimicrobial Bactericidal Activity in Mycobacterium abscessus
- (2014) Florian P. Maurer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial activity of rifamycins for M. smegmatis with comparison of oxidation and binding to tear lipocalin
- (2014) Tamara Staudinger et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents
- (2014) Suresh B. Lakshminarayana et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections
- (2014) R. J. Wallace et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Interception of host angiogenic signalling limits mycobacterial growth
- (2014) Stefan H. Oehlers et al. NATURE
- An antibiotic comeback?
- (2014) NATURE REVIEWS DRUG DISCOVERY
- The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells
- (2014) Véronique Dartois NATURE REVIEWS MICROBIOLOGY
- A rifamycin inactivating phosphotransferase family shared by environmental and pathogenic bacteria
- (2014) P. Spanogiannopoulos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis
- (2013) Lluís Ballell et al. ChemMedChem
- In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex
- (2013) M. Lavollay et al. CLINICAL MICROBIOLOGY AND INFECTION
- Characterization of broad-spectrum Mycobacterium abscessus class A -lactamase
- (2013) D. Soroka et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vivo Evaluation of Antibiotic Activity Against Mycobacterium abscessus
- (2013) Isabelle Lerat et al. JOURNAL OF INFECTIOUS DISEASES
- Host-Directed Therapeutics for Tuberculosis: Can We Harness the Host?
- (2013) T. R. Hawn et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Characterization of a Rifampin-Inactivating Glycosyltransferase from a Screen of Environmental Actinomycetes
- (2012) Peter Spanogiannopoulos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efflux Pumps of Mycobacterium tuberculosis Play a Significant Role in Antituberculosis Activity of Potential Drug Candidates
- (2012) Meenakshi Balganesh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Update on rifampin, rifabutin, and rifapentine drug interactions
- (2012) Anne M. Baciewicz et al. CURRENT MEDICAL RESEARCH AND OPINION
- Therapy of refractory nontuberculous mycobacterial lung disease
- (2012) David E. Griffith et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria
- (2012) Jakko van Ingen et al. DRUG RESISTANCE UPDATES
- HowMycobacterium tuberculosisgoes to sleep: the dormancy survival regulator DosR a decade later
- (2012) Calvin Boon et al. Future Microbiology
- Recognition of Imipenem and Meropenem by the RND-Transporter MexB Studied by Computer Simulations
- (2012) Francesca Collu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism
- (2011) Kristin N. Adams et al. CELL
- Imatinib-Sensitive Tyrosine Kinases Regulate Mycobacterial Pathogenesis and Represent Therapeutic Targets against Tuberculosis
- (2011) Ruth J. Napier et al. Cell Host & Microbe
- Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
- (2011) J. van Ingen et al. CLINICAL INFECTIOUS DISEASES
- Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
- (2011) Julie Jarand et al. CLINICAL INFECTIOUS DISEASES
- Experience with rifabutin replacing rifampin in the treatment of tuberculosis
- (2011) D.J. Horne et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae
- (2011) S. Chopra et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparative Genomics of the Dormancy Regulons in Mycobacteria
- (2011) A. Gerasimova et al. JOURNAL OF BACTERIOLOGY
- Clinical Significance of Differentiation ofMycobacterium massiliensefromMycobacterium abscessus
- (2010) Won-Jung Koh et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy
- (2010) Kevin Pethe et al. Nature Communications
- Nontuberculous Pulmonary Mycobacteriosis in Denmark
- (2009) Claire Andréjak et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae
- (2009) K. A. Nash et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands
- (2009) Jakko van Ingen et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Non Mycobacterial Virulence Genes in the Genome of the Emerging Pathogen Mycobacterium abscessus
- (2009) Fabienne Ripoll et al. PLoS One
- Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands
- (2009) J van Ingen et al. THORAX
- Rifamycin antibiotic resistance by ADP-ribosylation: Structure and diversity of Arr
- (2008) J. Baysarowich et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA Interference Screen Identifies Abl Kinase and PDGFR Signaling in Chlamydia trachomatis Entry
- (2008) Cherilyn A. Elwell et al. PLoS Pathogens
- RNAi Screen Reveals an Abl Kinase-Dependent Host Cell Pathway Involved in Pseudomonas aeruginosa Internalization
- (2008) Julia F. Pielage et al. PLoS Pathogens
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started